国务院批复江苏自贸试验区生物医药全产业链开放创新发展方案

Core Viewpoint - The State Council has approved the "Open Innovation Development Plan for the Entire Biopharmaceutical Industry Chain in China (Jiangsu) Free Trade Zone," marking significant policy support for the biopharmaceutical sector in Jiangsu [1][2] Group 1: Policy and Implementation - The plan aims to transform the Jiangsu Free Trade Zone into a globally influential biopharmaceutical industry hub with enhanced international competitiveness [1] - The implementation will be guided by Xi Jinping's thoughts and the principles from the 20th National Congress of the Communist Party, focusing on high-quality development and a new development pattern [1] - Jiangsu provincial government is responsible for developing a special plan, accelerating implementation, and ensuring the achievement of the plan's objectives [1] Group 2: Industry Development and Achievements - Jiangsu's biopharmaceutical industry has a comprehensive range of sectors and strong upstream and downstream capabilities, with the industry accounting for nearly half of the province's total output value [2] - The plan includes 18 key tasks across five areas, focusing on R&D innovation, major innovation platform construction, and regulatory reforms [2] - Jiangsu has been recognized for its strong biopharmaceutical industry, with several industrial parks ranked among the top 50 nationwide, and the Suzhou Industrial Park leading in comprehensive competitiveness [2]